Log in to save to my catalogue

Intrapulmonary Pharmacokinetics of Laninamivir, A Neuraminidase Inhibitor After A Single Nebulized A...

Intrapulmonary Pharmacokinetics of Laninamivir, A Neuraminidase Inhibitor After A Single Nebulized A...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1912663794

Intrapulmonary Pharmacokinetics of Laninamivir, A Neuraminidase Inhibitor After A Single Nebulized Administration of Laninamivir Octanoate In Healthy Subjects

About this item

Full title

Intrapulmonary Pharmacokinetics of Laninamivir, A Neuraminidase Inhibitor After A Single Nebulized Administration of Laninamivir Octanoate In Healthy Subjects

Author / Creator

Publisher

Bridgewater: Elsevier Inc

Journal title

Clinical therapeutics, 2017-08, Vol.39 (8), p.e26-e26

Language

English

Formats

Publication information

Publisher

Bridgewater: Elsevier Inc

More information

Scope and Contents

Contents

Background A single inhaled dosing of laninamivir octanoate (LO) using a dry powder inhaler (DPI) exhibits appropriate efficacy to treat both adult and pediatric patients with influenza virus infection. Subgroups of 6 subjects each underwent bronchoalveolar lavage (BAL) at specified time intervals from 4 to 168 h following a single...

Alternative Titles

Full title

Intrapulmonary Pharmacokinetics of Laninamivir, A Neuraminidase Inhibitor After A Single Nebulized Administration of Laninamivir Octanoate In Healthy Subjects

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1912663794

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1912663794

Other Identifiers

ISSN

0149-2918

E-ISSN

1879-114X

DOI

10.1016/j.clinthera.2017.05.079

How to access this item